Background: Systemic lupus erythematosus (SLE) is a complex and heterogenous
autoimmune disease characterised by periods of worsening symptoms, known as flares …

Recommendations represent a popular way of integrating evidence-based medicine to
clinical practice. These systematically developed statements can assist practitioner and …

Background: Healthcare quality for systemic lupus erythematosus (SLE) is a modifiable
target for improving patient outcomes. Disease-specific subspecialty clinics offer …

We have read the recently published update of the EULAR recommendations for the
management of systemic lupus erythematosus (SLE) recommendations 1 with great interest …

Background Systemic lupus erythematosus (SLE) prognosis is determined by a wide range
of factors, such as the severity of the disease manifestations, the psychosocial aspects of …

Systemic lupus erythematosus (SLE) is a prototypic chronic autoimmune disease
characterized by multisystem manifestations, with organ-based pathology predominantly …

Background: The current goal of treatment in SLE is remission or low disease activity (LDA)
and prevention of flares, achieved with the lowest possible dose of glucocorticoids …

Clinical heterogeneity, unpredictable course and flares are characteristics of systemic lupus
erythematosus (SLE). Although SLE is—by and large—a systemic disease, occasionally it …

Abstract Background/Aims In 2018, following BSR Lupus guidelines publication, we took
part in the national multicentre Lupus audit. Audit standards developed by expert consensus …

Background Quality of care is receiving increased attention in systemic lupus erythematosus
(SLE). We developed quality indicators (QIs) for SLE based on the 2019 update of European …